NCT07743736

Brief Summary

Cesarean delivery is a common surgical procedure associated with postoperative pain, anxiety, and reduced maternal comfort during the early postpartum period. Non-pharmacological interventions such as aromatherapy and massage have been suggested as supportive approaches for improving maternal well-being; however, further evidence is needed regarding their effectiveness after cesarean delivery. This randomized controlled trial aims to evaluate the effects of aromatherapy inhalation and aromatherapy-assisted back massage on postoperative pain, anxiety, and postpartum comfort in women after cesarean delivery. Participants who meet the eligibility criteria will be randomly assigned to three groups: an aromatherapy inhalation group, an aromatherapy-assisted back massage group, and a placebo group receiving sterile water inhalation as a simulation. Interventions will be initiated after cesarean delivery, and outcomes will be assessed using the Visual Analog Scale for pain intensity, the State-Trait Anxiety Inventory for anxiety level, and the Postpartum Comfort Scale for comfort level. This study is expected to provide information about the potential contribution of complementary non-pharmacological interventions to maternal recovery after cesarean delivery.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
90

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Feb 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 23, 2026

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

July 29, 2026

Completed
2 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 31, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2026

Completed
4 days until next milestone

First Posted

Study publicly available on registry

August 4, 2026

Completed
Last Updated

August 4, 2026

Status Verified

July 1, 2026

Enrollment Period

5 months

First QC Date

July 29, 2026

Last Update Submit

July 29, 2026

Conditions

Keywords

Cesarean deliveryPostoperative painAromatherapyPostpartum comfortRandomized controlled trialAnxiety

Outcome Measures

Primary Outcomes (1)

  • Postoperative pain intensity

    Pain intensity will be assessed using the Visual Analog Scale (VAS), a 0-10 scale in which higher scores indicate greater pain intensity.

    From 6 to 42 hours after cesarean delivery (before and after each intervention session)

Secondary Outcomes (2)

  • Anxiety level

    Before the first intervention session and after the final intervention session (42 hours after cesarean delivery).

  • Postpartum comfort level

    Before the first intervention session and after the final intervention session (42 hours after cesarean delivery).

Study Arms (3)

Aromatherapy Inhalation Group

EXPERIMENTAL

Participants in this group will receive aromatherapy inhalation beginning at the 6th postoperative hour after cesarean delivery. The intervention will be administered at 6, 18, 30, and 42 hours after surgery using Rosa damascena essential oil according to the study protocol. Pain, anxiety, and postpartum comfort outcomes will be assessed before and after the intervention sessions according to the study protocol.

Behavioral: Aromatherapy Inhalation

Aromatherapy-Assisted Back Massage Group

EXPERIMENTAL

Participants in this group will receive aromatherapy-assisted back massage starting at the 6th postoperative hour after cesarean delivery. The intervention will be administered at 6, 18, 30, and 42 hours after surgery. Back massage will be performed using Rosa damascena essential oil diluted with a carrier oil according to the study protocol. Pain, anxiety, and postpartum comfort outcomes will be assessed before and after each intervention session.

Behavioral: Aromatherapy-Assisted Back Massage

Placebo Group

PLACEBO COMPARATOR

Participants in this group will receive placebo inhalation beginning at the 6th postoperative hour after cesarean delivery. The intervention will be administered at 6, 18, 30, and 42 hours after surgery using sterile water as a simulation of aromatherapy according to the study protocol. Pain, anxiety, and postpartum comfort outcomes will be assessed before and after the intervention sessions according to the study protocol.

Behavioral: placebo inhalation

Interventions

Participants will receive aromatherapy inhalation using Rosa damascena essential oil beginning at the 6th postoperative hour after cesarean delivery. For each session, 2 drops of Rosa damascena essential oil will be applied to a sterile gauze and held approximately 10 cm from the participant's nose. Participants will breathe normally during the inhalation period. The intervention will be performed at 6, 18, 30, and 42 hours after surgery, with each session lasting 10 minutes.

Aromatherapy Inhalation Group

Participants will receive aromatherapy-assisted back massage beginning at the 6th postoperative hour after cesarean delivery. The massage will be applied to the upper and lower back regions using Rosa damascena essential oil diluted to 3% with sweet almond carrier oil. The intervention will be performed at 6, 18, 30, and 42 hours after surgery according to the study protocol. Participants will be positioned in a comfortable lateral or sitting position during the massage application.

Aromatherapy-Assisted Back Massage Group

Participants will receive placebo inhalation using sterile water as a simulation of aromatherapy. The intervention will begin at the 6th postoperative hour after cesarean delivery and will be administered at 6, 18, 30, and 42 hours after surgery. Each session will follow the same procedure and duration as the aromatherapy inhalation group according to the study protocol.

Placebo Group

Eligibility Criteria

Age18 Years - 40 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsWomen
Healthy VolunteersNo
Age GroupsAdult (18-64)
Women aged 18-40 years Primiparous women Undergoing cesarean delivery under spinal anesthesia Term pregnancy (38-42 gestational weeks) Able to communicate and complete study questionnaires Willing to participate and provide written informed consent No known allergy to essential oils Intact sense of smell

Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.

Sponsors & Collaborators

Study Sites (1)

Usak University Training and Research Hospital

Uşak, Uşak, 64200, Turkey (Türkiye)

RECRUITING

MeSH Terms

Conditions

Pain, PostoperativeAnxiety Disorders

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and SymptomsMental Disorders

Central Study Contacts

ŞEYMA ÇATALGÖL, Dr

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: Participants will be randomly assigned to one of three parallel groups: aromatherapy inhalation, aromatherapy-assisted back massage, or placebo group. Outcomes will be compared between groups after the intervention period.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dr

Study Record Dates

First Submitted

July 29, 2026

First Posted

August 4, 2026

Study Start

February 23, 2026

Primary Completion

July 31, 2026

Study Completion

July 31, 2026

Last Updated

August 4, 2026

Record last verified: 2026-07

Data Sharing

IPD Sharing
Will not share

Locations